Literature DB >> 32673144

A novel treatment of a patient with a giant ruptured middle cerebral artery aneurysm by acute coiling followed by scheduled Pipeline flex placement.

Shikai Liang1, Ren Yuan1, Xianli Lv1.   

Abstract

OBJECTIVE: Flow diversion in the acute phase of aneurysm rupture or giant aneurysm is limited by the need for dual antiplatelet therapy and the risk of delayed aneurysm rupture. Here, the authors report a scheduled flow-diversion concept for the endovascular treatment of a giant intra-dural aneurysm.
METHODS: A 54-year-old female patient with a ruptured giant middle cerebral artery aneurysm underwent coiling in the acute phase following 1-month scheduled Pipeline flex placement.
RESULTS: The acutely ruptured giant middle cerebral artery aneurysm was treated by flow diversion scheduled at 1 month after conventional coiling. The patient tolerated this treatment strategy well without any neurological deficits after the procedure and during the 3-month follow-up. The aneurysm showed nearly complete obliteration on 3-month follow-up angiogram, and a 6- to 12-month follow-up was scheduled.
CONCLUSIONS: This strategy may be considered as an option in patients presenting with ruptured or unruptured giant intra-dural aneurysms.

Entities:  

Keywords:  Rupture; coil; flow diversion; giant aneurysm; scheduled

Year:  2020        PMID: 32673144      PMCID: PMC7788672          DOI: 10.1177/1971400920941192

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  11 in total

Review 1.  Flow-diverter devices in the treatment of intracranial aneurysms: A meta-analysis and systematic review.

Authors:  Xianli Lv; Hongchao Yang; Peng Liu; Youxiang Li
Journal:  Neuroradiol J       Date:  2016-02-02

2.  A systematic review of pipeline embolization device for giant intracranial aneurysms.

Authors:  Xianli Lv; Huijian Ge; Hongwei He; Chuhan Jiang; Youxiang Li
Journal:  Neurol India       Date:  2017 Jan-Feb       Impact factor: 2.117

3.  The philosophy of 'unity of knowledge and action' in interventional neuroradiology teaching.

Authors:  Xianli Lv; Zhongxue Wu
Journal:  Neuroradiol J       Date:  2017-06-29

4.  Immediate and midterm results following treatment of recently ruptured intracranial aneurysms with the Pipeline embolization device.

Authors:  W McAuliffe; J D Wenderoth
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-01       Impact factor: 3.825

5.  Late rebleeding of ruptured intracranial aneurysms treated with detachable coils.

Authors:  Menno Sluzewski; Willem Jan van Rooij; Guus N Beute; Peter C Nijssen
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

Review 6.  Mechanisms of Healing in Coiled Intracranial Aneurysms: A Review of the Literature.

Authors:  W Brinjikji; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2014-11-27       Impact factor: 3.825

7.  Treatment of ruptured intracranial aneurysms with the pipeline embolization device.

Authors:  Nohra Chalouhi; Mario Zanaty; Alex Whiting; Stavropoula Tjoumakaris; David Hasan; Norman Ajiboye; Shannon Hann; Robert H Rosenwasser; Pascal Jabbour
Journal:  Neurosurgery       Date:  2015-02       Impact factor: 4.654

8.  Concurrent use of the Pipeline Embolization Device and coils for intracranial aneurysms: technique, safety, and efficacy.

Authors:  Erez Nossek; David J Chalif; Shamik Chakraborty; Kim Lombardo; Karen S Black; Avi Setton
Journal:  J Neurosurg       Date:  2015-02-06       Impact factor: 5.115

9.  Treatment of ruptured complex and large/giant ruptured cerebral aneurysms by acute coiling followed by staged flow diversion.

Authors:  Waleed Brinjikji; Mariangela Piano; Shanna Fang; Guglielmo Pero; David F Kallmes; Luca Quilici; Luca Valvassori; Emilio Lozupone; Harry J Cloft; Edoardo Boccardi; Giuseppe Lanzino
Journal:  J Neurosurg       Date:  2015-12-11       Impact factor: 5.115

10.  Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device.

Authors:  W Brinjikji; G Lanzino; H J Cloft; A H Siddiqui; R A Hanel; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.